SedmanABKleinGLMerrittRJEvidence of aluminum loading in infants receiving intravenous therapy. N Engl J Med1985; 312: 1337–43.
2.
MorenoADomínguezCBallabrigaA. Aluminium in the neonate related to parenteral nutrition. Acta Paediatr (in press).
3.
BishopNJRobinsonMJLendonMHewittCDDayJPO'HaraM. Increased concentration of aluminium in the brain of a parenterally fed preterm infant. Arch Dis Child1989; 64: 1316–7.
4.
KleinGLAlfreyACShikeMSherrardDJ. Parenteral drug products containing aluminum as an ingredient or a contaminant: response to FDA notice of intent. Am J Clin Nutr1991; 53: 399–402.
5.
LioneA. Aluminum toxicology and the aluminum-containing medications. Pharmacol Ther1985; 29: 255–85.
6.
FellGSShenkinAHallsDJ. Aluminium contamination of intravenous pharmaceuticals, nutrients, and blood products (letter). Lancet1986; 1: 380.
DomínguezCMorenoABallabrigaA. DNA synthesis stimulation by aluminium ions in human fibroblasts cultured in vitro. In: SunshineI, ed. Therapeutic Drug Monitoring and Toxicology. New York: Marcel Dekker, 1992: 751–8.
